Amgevita and Idacio exhibited higher rates than methotrexate at both week 24 and week 52 suggesting adalimumab biosimilars provided superior treatment persistence among patients with moderate-to-severe psoriasis.
/PRNewswire/ GenesisCare, one of the largest oncology care providers in the U.S., announced its 50th location to offer its innovative Skinviva™ program for.
Due to the disease’s chronicity, the variability in treatment response and drug safety profiles, and the availability of multiple therapies, switching or discontinuing treatments is common in psoriasis.